SIMVASTATIN

Product NDC
68788-8406
11-digit product format
687888406
Labeler code
68788
Product ID
68788-8406_1543148a-712a-4cae-881a-105deb09d756
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
SIMVASTATIN
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Preferred Pharmaceuticals, Inc.
Application
ANDA078103
Marketing category
ANDA
Marketing start
2023-03-29
Substance
SIMVASTATIN
Active strength
80 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

openFDA Listing Details

Product ID
68788-8406_1543148a-712a-4cae-881a-105deb09d756
Product type
HUMAN PRESCRIPTION DRUG
Finished product
Yes
Brand name base
SIMVASTATIN
Generic name
SIMVASTATIN
Dosage form
TABLET, FILM COATED
Route
ORAL
Marketing start
2023-03-29
Marketing category
ANDA
Application number
ANDA078103
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
Listing expiration
2026-12-31

Related Records

openFDA Active Ingredients

IngredientStrength
SIMVASTATIN80 mg/1

openFDA Harmonized Identifiers

FieldValues
UniiAGG2FN16EV
Rxcui200345
Spl Set Id68f6c856-ea98-4872-b4df-a6e9e70444fc
Manufacturer NamePreferred Pharmaceuticals, Inc.

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
AGG2FN16EVSIMVASTATIN79902-63-9SIMVASTATIN

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
68788-8406-168788840601100 TABLET, FILM COATED in 1 BOTTLE (68788-8406-1) 2023-03-29NoNoCurrent
68788-8406-36878884060330 TABLET, FILM COATED in 1 BOTTLE (68788-8406-3) 2023-03-29NoNoCurrent
68788-8406-66878884060660 TABLET, FILM COATED in 1 BOTTLE (68788-8406-6) 2023-03-29NoNoCurrent
68788-8406-96878884060990 TABLET, FILM COATED in 1 BOTTLE (68788-8406-9) 2023-03-29NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
SIMVASTATINPreferred Pharmaceuticals, Inc.2025-09-23HUMAN PRESCRIPTION DRUG LABEL3